Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Human error” that saw a man given an “inappropriate and excessive” dose of a drug while admitted to the Mersey Community ...

Lawyers for AstraZeneca , Bristol Myers Squibb and Johnson & Johnson's Janssen on Wednesday urged a federal appeals court in ...

When it comes to drug pricing, the Trump and Biden-Harris administrations both have some very modest wins to tout. As ...

Half of renally-cleared rivaroxaban is cleared as unchanged drug and half as inactive metabolites. ‡Potent inhibitors of both CYP3A4 and P-gp include azole antifungals (e.g., ketoconazole ...

President Joe Biden will deliver remarks on prescription drug costs at an event in New Hampshire on Tuesday. Biden is ...

Last month, J&J announced it would change payment terms for its Xarelto blood thinner and the ... To ensure the program achieves this goal, drug companies that want to take part in Medicare ...

Late last week, J&J said that the new approach for Xarelto and Stelara – both drugs ... being fought between the HHS, drug manufacturers, and 340B hospitals, the latter claiming that without ...

What you need to know Intravenous thrombolytics, including the recombinant tissue plasminogen activators alteplase or ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

Johnson & Johnson has dropped plans to change the way it offers drug discounts to certain hospitals ... for psoriasis and the blood thinner Xarelto–and then apply for rebates to be paid later.

In August, Johnson & Johnson announced new reimbursement plans for its anticoagulant Xarelto and Stelara, a Crohn's disease drug, at 340B-participating hospitals. Under the proposed switch ...